This study is a clinical trial. Participants will be selected from infertile patients under the age of 40 who are referred to the Yas Infertility Center who are candidates for embryo transfer. Patients with genetic disease diagnosed in their own or spouse, people with a specific systemic or chronic disease (diabetes, hypertension, endocrine problems, autoimmune diseases, endometriosis, etc.) are excluded. All embryos have been frozen in quality a and b. On this basis, 90 patients were enrolled in the study and randomly divided into two groups of experimental and control groups. Two weeks before the start of the cycle, patients undergo vaginal examination. In the event of any vaginal infection, they were excludedl. Then, in the experimental group, the vaginal microbial suppository (lactate) as a nocturnal adminstrated for one week. Then, on the second day of mens, they will refer to endometrial preparations. In the control group, patients do not receive microbial supplements, and on the second day they refer to the uterus for freeze transfer. The process of endometrial preparation is according to the current protocol. According to the age of the patient, 1 to 3 fetuses a and b are transmitted to the uterus on the fifth day. In case of severe and severe transfusion, or return of the fetus to the catheter, the patient is excluded from the study. After that, the outcome of pregnancy will be compared to the two groups.